By directly labeling inhaler canisters with our patient label instead of the
outside box we were able to reduce requests for replacement doses.
We considered using ‘spacers’ but there were too many failure points that our
P&T Committte decided against it.
From: nyschp.dop-bounce@xxxxxxxxxxxxx [mailto:nyschp.dop-bounce@xxxxxxxxxxxxx] ;
On Behalf Of Vickie Powell
Sent: Wednesday, November 27, 2019 9:20 AM
To: nyschp.dop@xxxxxxxxxxxxx
Subject: [nyschp.dop] Re: [EXTERNAL] Re: Common Canister
CAUTION: This Email is sent from outside our organization. Please DO NOT Click
on any links or open any attachments unless you recognize the sender.
Please forward any Suspicious Email "as an attachment" to
MISSOC@xxxxxxxxxxxx<mailto:missoc@xxxxxxxxxxxx>
Same as Frank
Vickie
Vickie Powell, BS, PharmD, MS, FASHP
Site Director, Pharmacy
New York-Presbyterian Hospital
The Allen Hospital
Lawrence Hospital
Morgan Stanley Children’s Hospital
622 West 168th Street<x-apple-data-detectors://12/1>
New York, New York 10032<x-apple-data-detectors://12/1>
212-305-7894<tel:212-305-7894> (Office Telephone)
212-305-7890<tel:212-305-7890> (Fax)
347-585-8190<tel:347-585-8190> (Mobile)
Pager: 81500<tel:81500>
Vip9006@xxxxxxx<mailto:Vip9006@xxxxxxx>
From: nyschp.dop-bounce@xxxxxxxxxxxxx<mailto:nyschp.dop-bounce@xxxxxxxxxxxxx>
<nyschp.dop-bounce@xxxxxxxxxxxxx<mailto:nyschp.dop-bounce@xxxxxxxxxxxxx>> On
Behalf Of Frank Sosnowski
Sent: Wednesday, November 27, 2019 7:17 AM
To: nyschp.dop@xxxxxxxxxxxxx<mailto:nyschp.dop@xxxxxxxxxxxxx>
Subject: [EXTERNAL] [nyschp.dop] Re: Common Canister
Been discussing it for years. No uptake. Concern infectious disease.
Sent from my iPhone
On Nov 21, 2019, at 12:47 PM, Sandra Obleman
<sobleman@xxxxxxxxxxxxxxxx<mailto:sobleman@xxxxxxxxxxxxxxxx>> wrote:
Hello Everyone,
Have any of you switched over to Common Canister for your inhalers and are also
surveyed by the Joint Commission? We are considering the switch over because
it is a significant cost savings, because we all know how inhalers tend to get
lost which results in a lot of wasted money.
My question is, how is common canister viewed by the Joint Commission? I have
done some research but I cannot find anything specific to the Joint Commission
and their views on common canister.
Thanks
Sandy
<image001.jpg>
Sandra Obleman, PharmD, RPh
Director of Pharmacy| Oswego Health
110 West Sixth Street | Oswego, NY 13126
office: 315-349-5719 |
e-mail:sobleman@xxxxxxxxxxxxxxxx<mailto:sobleman@xxxxxxxxxxxxxxxx>
________________________________
This communication is from Oswego Health, Inc., or an affiliate, and is
intended solely for the use of the individual or entity to which it is
addressed. Information contained herein may include privileged and/or
confidential information. Unauthorized review, forwarding, printing, copying,
distributing or using such information is strictly prohibited and may be
unlawful. If you received this message in error or if you are otherwise
unauthorized to receive it, please promptly return to sender via email with a
copy to
privacyofficer@xxxxxxxxxxxxxxxx<mailto:privacyofficer@xxxxxxxxxxxxxxxx>, then
delete the original message and destroy all copies. Thank you.
________________________________
This electronic message is intended to be for the use only of the named
recipient, and may contain information that is confidential or privileged. If
you are not the intended recipient, you are hereby notified that any
disclosure, copying, distribution or use of the contents of this message is
strictly prohibited. If you have received this message in error or are not the
named recipient, please notify us immediately by contacting the sender at the
electronic mail address noted above, and delete and destroy all copies of this
message. Thank you.
code:d34y
CONFIDENTIALITY NOTICE: This communication and any attachments may contain
confidential and/or privileged information for the use of the designated
recipients named above. If you are not the intended recipient, you are hereby
notified that you have received this communication in error and that any
review, disclosure, dissemination, distribution or copying of it or its
contents is prohibited. If you have received this communication in error,
please notify the sender immediately by email or telephone and destroy all
copies of this communication and any attachments.
